As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »
Text size And so it begins. The Nasdaq Composite has been going up for so long now, it’s hard to remember if it feels like it’s going down. Now we know. Yes, that’s an exaggeration, but not much. He had been active for seven of the past nine trading days …
Read More »
Shares of Pfizer Inc. PFE, + 1.10% gathered 2.3% and BioNTech SE BNTX, + 7.24% On Monday, it rose 5.3% in premarket trading, after companies said two of their vaccine candidates to protect themselves against the virus that causes COVID-19 received the Fast Track designation status from the Administration. Food …
Read More »
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »
Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »